• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双相(99m)Tc-MIBI乳腺闪烁显像中早期和延迟定量指标在原发性乳腺癌检测中的比较

Comparison of early and delayed quantified indices of double-phase (99m)Tc MIBI scintimammography in the detection of primary breast cancer.

作者信息

Kim S J, Kim I J, Bae Y T, Kim Y K, Kim D S

机构信息

Department of Nuclear Medicine, College of Medicine, Pusan National University, Pusan, Korea.

出版信息

Acta Radiol. 2005 Apr;46(2):148-54. doi: 10.1080/02841850510020752.

DOI:10.1080/02841850510020752
PMID:15902889
Abstract

PURPOSE

To compare the diagnostic accuracy and incremental diagnostic role of quantitative indices of early and delayed lesion to non-lesion ratios (L/Ns) in the detection of primary breast cancer.

MATERIAL AND METHODS

Double-phase (99m)Tc MIBI scintimammography (SMM) (early 10 min, delayed 3 h) was performed after injection of 750 MBq of (99m)Tc MIBI in 446 highly suspected breast cancer patients (malignant: 311, benign: 135). For visual analysis, five scoring methods were used, and, for quantitative analysis, early and delayed L/Ns were calculated. Receiver operating characteristic curve (ROC) analyses were performed to determine the optimal visual grade, and to calculate cut-off values of quantitative indices for differentiation of malignant and benign diseases and to investigate whether the quantitative indices could provide incremental diagnostic values in addition to visual analysis.

RESULTS

Optimal visual grades were above 4 and 5 in the detection of breast cancer. Sensitivity was 84.2% and specificity 79.3%; the area under the curve (AUC) was 0.832 (95% CI, 0.794-0.866) and standard error was 0.019. Early and delayed L/Ns of malignant breast disease were significantly higher than those of benign disease (early: 2.01 +/- 0.99 versus 1.13 +/- 0.26 (P < 0.001); delayed: 1.68 +/- 0.69 versus 1.11 +/- 0.23 (P < 0.001)). The optimal L/Ns for the detection of primary breast cancer were 1.27 for early and 1.12 for delayed imaging. When early L/N 1.27 was used as cut-off value for the detection of primary breast cancer, the sensitivity of SMM was 77.8% and specificity 85.2%. The AUC was 0.856 (95% CI, 0.820-0.888). When delayed L/N 1.12 was used, sensitivity and specificity were 81.4% and 78.5%, respectively. The AUC was 0.834 (95% CI, 0.796-0.867). The ROC comparison of early and delayed L/N showed no statistical difference in the detection of malignant breast disease (P=0.403). When the delayed L/N was added to the early one, early plus delayed quantitative analysis (E+D) showed 86.5% sensitivity and 74.8% specificity. However, the AUCs of E+D (0.854, 95% CI, 0.767-0.842) and early L/N (E) (0.856) showed no statistical difference (P=0.614). When grades 4 and 5 were used as cut-off visual grade, sensitivity and specificity were 84.2% and 79.3%, respectively. When the E was added to visual grade, visual plus early L/N (V+E) showed 89.4% sensitivity and 77% specificity. The AUC of V+E (0.867, 95% CI, 0.832 0.897) was significantly higher than that of visual analysis (V) (0.832, 95% CI, 0.794-0.866, P < 0.001). When the delayed L/N (D) was added to visual grade, visual plus delayed L/N (V+D) showed 89.4% sensitivity and 74.1% specificity. The AUCs of V+D (0.852, 95% CI, 0.816-0.884) and V revealed no statistical differences (P = 0.052).

CONCLUSION

From this study, the optimal visual grades for diagnosis of breast cancer were grades 4 and 5; the cut-off values of L/Ns were 1.27 for early and 1.12 for delayed imaging. It was also found that early L/Ns provide incremental value in addition to visual analysis. However, delayed L/N revealed no incremental value. Therefore, the delayed image should not be routinely performed for purposes of primary breast cancer detection

摘要

目的

比较早期和延迟病变与非病变比值(L/N)的定量指标在原发性乳腺癌检测中的诊断准确性和增量诊断作用。

材料与方法

对446例高度怀疑乳腺癌的患者(恶性:311例,良性:135例)注射750MBq的(99m)Tc MIBI后进行双期(99m)Tc MIBI乳腺闪烁显像(SMM)(早期10分钟,延迟3小时)。视觉分析采用五种评分方法,定量分析计算早期和延迟的L/N。进行受试者操作特征曲线(ROC)分析以确定最佳视觉等级,计算区分恶性和良性疾病的定量指标临界值,并研究定量指标除视觉分析外是否能提供增量诊断价值。

结果

乳腺癌检测的最佳视觉等级在4级及以上。敏感性为84.2%,特异性为79.3%;曲线下面积(AUC)为0.832(95%CI,0.794 - 0.866),标准误为0.019。恶性乳腺疾病的早期和延迟L/N显著高于良性疾病(早期:2.01±0.99对1.13±0.26(P < 0.001);延迟:1.68±0.69对1.11±0.23(P < 0.001))。原发性乳腺癌检测的最佳L/N,早期为1.27,延迟显像为1.12。当早期L/N 1.27用作原发性乳腺癌检测的临界值时,SMM的敏感性为77.8%,特异性为85.2%。AUC为0.856(95%CI,0.820 - 0.888)。当使用延迟L/N 1.12时,敏感性和特异性分别为81.4%和78.5%。AUC为0.834(95%CI,0.796 - 0.867)。早期和延迟L/N的ROC比较显示在恶性乳腺疾病检测中无统计学差异(P = 0.403)。当将延迟L/N加到早期L/N上时,早期加延迟定量分析(E + D)显示敏感性为86.5%,特异性为74.8%。然而,E + D的AUC(0.854,95%CI,0.767 - 0.842)和早期L/N(E)(0.856)无统计学差异(P = 0.614)。当4级和5级用作临界视觉等级时,敏感性和特异性分别为84.2%和79.3%。当将E加到视觉等级上时,视觉加早期L/N(V + E)显示敏感性为89.4%,特异性为77%。V + E的AUC(0.867,95%CI,0.832 - 0.897)显著高于视觉分析(V)(0.832,95%CI,0.794 - 0.866,P < 0.001)。当将延迟L/N(D)加到视觉等级上时,视觉加延迟L/N(V + D)显示敏感性为89.4%,特异性为74.1%。V + D的AUC(0.852,95%CI,0.816 - 0.884)和V无统计学差异(P = 0.052)。

结论

本研究中,乳腺癌诊断的最佳视觉等级为4级和5级;L/N的临界值,早期为1.27,延迟显像为1.12。还发现早期L/N除视觉分析外提供增量价值。然而,延迟L/N未显示增量价值。因此,对于原发性乳腺癌检测,不应常规进行延迟显像。

相似文献

1
Comparison of early and delayed quantified indices of double-phase (99m)Tc MIBI scintimammography in the detection of primary breast cancer.双相(99m)Tc-MIBI乳腺闪烁显像中早期和延迟定量指标在原发性乳腺癌检测中的比较
Acta Radiol. 2005 Apr;46(2):148-54. doi: 10.1080/02841850510020752.
2
Incremental diagnostic value of quantitative analysis of double phase Tc-99m MIBI scintimammography for the detection of primary breast cancer additive to visual analysis.双期Tc-99m甲氧基异丁基异腈乳腺闪烁显像定量分析对原发性乳腺癌检测的增量诊断价值:视觉分析之外的补充作用
Breast Cancer Res Treat. 2004 Jan;83(2):129-38. doi: 10.1023/B:BREA.0000010705.31599.89.
3
Comparison of quantitative and visual analysis of Tc-99m MIBI scintimammography for detection of primary breast cancer.用于检测原发性乳腺癌的Tc-99m MIBI乳腺闪烁显像定量分析与视觉分析的比较。
Eur J Radiol. 2005 Feb;53(2):192-8. doi: 10.1016/j.ejrad.2003.10.024.
4
Characterization of breast lesion using double phase Tc-99m Tetrofosmin scintimammography: comparison of visual and quantitative analyses.使用双期 Tc-99m 替曲膦乳腺闪烁显像术对乳腺病变进行特征描述:视觉分析与定量分析的比较
Eur J Radiol. 2006 Jan;57(1):76-80. doi: 10.1016/j.ejrad.2005.07.011. Epub 2005 Aug 26.
5
Comparison of double phase Tc-99m MIBI and Tc-99m tetrofosmin scintimammography for characterization of breast lesions: Visual and quantitative analyses.双相锝-99m甲氧基异丁基异腈与锝-99m四磷酰胺乳腺闪烁显像对乳腺病变特征的比较:视觉与定量分析
Neoplasma. 2008;55(6):526-31.
6
Diagnostic performances of double-phase tc-99m MIBI scintimammography in patients with indeterminate ultrasound findings: visual and quantitative analyses.双相锝-99m甲氧基异丁基异腈乳腺闪烁显像对超声检查结果不确定患者的诊断效能:视觉和定量分析
Ann Nucl Med. 2007 Jun;21(3):145-50. doi: 10.1007/s12149-006-0002-y.
7
Detection and prediction of breast cancer using double phase Tc-99m MIBI scintimammography in comparison with MRI.与MRI相比,使用双期Tc-99m MIBI乳腺闪烁显像术检测和预测乳腺癌
Onkologie. 2009 Oct;32(10):556-60. doi: 10.1159/000232316. Epub 2009 Sep 21.
8
Diagnostic value of (99m)Tc-3PRGD2 scintimammography for differentiation of malignant from benign breast lesions: Comparison of visual and semi-quantitative analysis.(99m)Tc-3PRGD2乳腺闪烁显像对乳腺良恶性病变鉴别的诊断价值:视觉分析与半定量分析的比较
Hell J Nucl Med. 2015 Sep-Dec;18(3):193-8. doi: 10.1967/s002449910302. Epub 2015 Nov 18.
9
99mTc-3P4-RGD2 scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.99mTc-3P4-RGD2乳腺闪烁显像在乳腺病变评估中的应用:与99mTc-MIBI的对比研究
PLoS One. 2014 Sep 24;9(9):e108349. doi: 10.1371/journal.pone.0108349. eCollection 2014.
10
Determination and prediction of P-glycoprotein and multidrug-resistance-related protein expression in breast cancer with double-phase technetium-99m sestamibi scintimammography. Visual and quantitative analyses.用双时相99m锝-甲氧基异丁基异腈乳腺闪烁显像术测定和预测乳腺癌中P-糖蛋白及多药耐药相关蛋白的表达:视觉和定量分析
Oncology. 2006;70(6):403-10. doi: 10.1159/000098812. Epub 2007 Jan 18.

引用本文的文献

1
Real-time intraoperative detection of breast cancer using near-infrared fluorescence imaging and Methylene Blue.使用近红外荧光成像和亚甲蓝实时术中检测乳腺癌。
Eur J Surg Oncol. 2014 Jul;40(7):850-8. doi: 10.1016/j.ejso.2014.02.225. Epub 2014 Feb 22.